Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10947 | 31108934 | Nutrients | Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003⁻2014. | 2019 | Details |
| A10953 | 31105018 | Ann Hepatol | "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?" | 2019 | Details |
| A10959 | 31102719 | J Hepatol | New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. | 2019 | Details |
| A10964 | 31101130 | Lipids Health Dis | The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia. | 2019 | Details |
| A10976 | 31094472 | Ter Arkh | Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis. | 2019 | Details |
| A10980 | 31094076 | Obesity (Silver Spring) | Sub-phenotyping Metabolic Disorders Using Body Composition: An Individualized, Nonparametric Approach Utilizing Large Data Sets. | 2019 | Details |
| A10981 | 31094016 | Aliment Pharmacol Ther | Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. | 2019 | Details |
| A10990 | 31089474 | J Diabetes Res | Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link? | 2019 | Details |
| A10998 | 31085647 | Proc Natl Acad Sci U S A | sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. | 2019 | Details |
| A11007 | 31083413 | Int J Mol Sci | Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model. | 2019 | Details |
| A11013 | 31081997 | Liver Int | Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. | 2019 | Details |
| A11033 | 31076231 | Ultrasound Med Biol | Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound. | 2019 | Details |
| A11049 | 31068503 | Endocr J | High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men. | 2019 | Details |
| A11072 | 31057993 | Cureus | Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study. | 2019 | Details |
| A11080 | 31054977 | Ann Hepatol | Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China. | 2019 | Details |
| A11081 | 31054837 | Prim Care Diabetes | Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. | 2019 | Details |
| A11110 | 31037218 | J Nutr Sci | Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. | 2019 | Details |
| A11119 | 31034016 | J Clin Endocrinol Metab | Associations of plasma CD36 and body fat distribution. | 2019 | Details |
| A11132 | 31028903 | Pharmacol Res | Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH. | 2019 | Details |
| A11169 | 31012869 | JCI Insight | Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. | 2019 | Details |
| A11190 | 31005808 | Phytomedicine | Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice. | 2018 | Details |
| A11217 | 30991877 | Gut Microbes | High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. | 2019 | Details |
| A11222 | 30987634 | BMC Pediatr | Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard. | 2019 | Details |
| A11240 | 30978266 | PLoS One | Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. | 2019 | Details |
| A11280 | 30959577 | Hepatology | Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. | 2019 | Details |
| A11292 | 30952479 | J Formos Med Assoc | Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. | 2019 | Details |
| A11293 | 30951700 | Exp Mol Pathol | The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A11322 | 30938723 | Food Funct | Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11323 | 30937936 | J Cell Physiol | Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes. | 2019 | Details |
| A11339 | 30931332 | Biomed Res Int | Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11347 | 30928418 | Dig Liver Dis | Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11352 | 30926798 | Nat Commun | A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. | 2019 | Details |
| A11354 | 30925684 | Int J Mol Sci | The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice. | 2019 | Details |
| A11376 | 30919112 | Heart Vessels | High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes. | 2019 | Details |
| A11407 | 30907181 | Scand J Gastroenterol | Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11408 | 30907050 | Helicobacter | Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies. | 2019 | Details |
| A11426 | 30899974 | Eur Radiol | Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. | 2019 | Details |
| A11449 | 30889997 | Expert Opin Ther Pat | A patent update on cannabinoid receptor 1 antagonists (2015-2018). | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11462 | 30887196 | Eur Radiol | Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography. | 2019 | Details |
| A11468 | 30882933 | Aliment Pharmacol Ther | Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11469 | 30882706 | Medicine (Baltimore) | Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study. | 2019 | Details |
| A11485 | 30876959 | Clin Gastroenterol Hepatol | Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis. | 2019 | Details |
| A11489 | 30875494 | Atherosclerosis | Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. | 2019 | Details |
| A11493 | 30871980 | J Hepatol | Global liver disease burdens and research trends: Analysis from a Chinese perspective. | 2019 | Details |
| A11500 | 30870486 | PLoS One | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. | 2019 | Details |
| A11505 | 30868315 | Acta Diabetol | Oral glucose effectiveness and metabolic risk in obese children and adolescents. | 2019 | Details |
| A11514 | 30863439 | Gastroenterol Res Pract | Noninvasive Evaluation of Liver Function in Morbidly Obese Patients. | 2019 | Details |
| A11528 | 30856468 | J Nutr Biochem | Tissue-dependent effects of cis-9,trans-11- and trans-10,cis-12-CLA isomers on glucose and lipid metabolism in adult male mice. | 2019 | Details |
| A11531 | 30854954 | Curr Pharm Biotechnol | Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11547 | 30849036 | Cleve Clin J Med | Assessing liver fibrosis without biopsy in patients with HCV or NAFLD. | 2019 | Details |
| A11549 | 30848827 | J Clin Endocrinol Metab | Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. | 2019 | Details |
| A11573 | 30834274 | Biomed Res Int | Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. | 2019 | Details |
| A11588 | 30827925 | Clin Res Hepatol Gastroenterol | Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities. | 2019 | Details |
| A11603 | 30823422 | Nutrients | Dietary Sources of Fructose and Its Association with Fatty Liver in Mexican Young Adults. | 2019 | Details |
| A11604 | 30823334 | Environ Pollut | Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. | 2019 | Details |
| A11606 | 30822271 | Endocr Connect | Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease. | 2019 | Details |
| A11609 | 30820969 | Hepatology | Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways. | 2019 | Details |
| A11621 | 30815318 | Food Sci Biotechnol | Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease. | 2018 | Details |
| A11622 | 30815083 | AMIA Annu Symp Proc | Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients. | 2018 | Details |
| A11626 | 30813440 | Nutrients | Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial. | 2019 | Details |
| A11642 | 30808572 | Dig Liver Dis | Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people. | 2019 | Details |
| A11651 | 30805370 | Biomed Res Int | Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients. | 2019 | Details |
| A11654 | 30803094 | Microcirculation | Multi-domain analysis of microvascular flow motion dynamics in NAFLD. | 2019 | Details |
| A11673 | 30794300 | JAMA Netw Open | Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11708 | 30783789 | Eur Radiol | Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD. | 2019 | Details |
| A11717 | 30778334 | Front Endocrinol (Lausanne) | Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health. | 2019 | Details |
| A11733 | 30772307 | EBioMedicine | Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A11765 | 30761559 | Aliment Pharmacol Ther | Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. | 2019 | Details |
| A11774 | 30755685 | Sci Rep | Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. | 2019 | Details |
| A11851 | 30708109 | Clin Gastroenterol Hepatol | Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices. | 2019 | Details |
| A11854 | 30707422 | J Robot Surg | The impact of body mass index on perioperative outcomes after robotic liver resection. | 2019 | Details |
| A11855 | 30707282 | J Gastroenterol | Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis. | 2019 | Details |
| A11864 | 30705240 | BMJ Open | Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study. | 2019 | Details |
| A11894 | 30691143 | Nutrients | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome. | 2019 | Details |
| A11895 | 30690636 | Poult Sci | Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model. | 2019 | Details |
| A11911 | 30684076 | Dig Dis Sci | Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. | 2019 | Details |
| A11914 | 30683615 | Dig Liver Dis | Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A11926 | 30680004 | Exp Ther Med | Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1. | 2018 | Details |
| A11946 | 30671174 | Oxid Med Cell Longev | Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A11947 | 30671129 | Evid Based Complement Alternat Med | Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota. | 2018 | Details |
| A11950 | 30670907 | World J Gastroenterol | Current status, problems, and perspectives of non-alcoholic fatty liver disease research. | 2019 | Details |
| A11959 | 30668392 | Phytomedicine | Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor. | 2018 | Details |
| A11960 | 30667551 | J Gastroenterol Hepatol | Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11971 | 30661332 | J Exerc Nutrition Biochem | Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults. | 2018 | Details |
| A11974 | 30660825 | Pharmacol Res | Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites. | 2019 | Details |
| A12051 | 30622377 | World J Gastroenterol | Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease. | 2018 | Details |
| A12053 | 30621707 | Lipids Health Dis | Plasma lipidomic signatures of spontaneous obese rhesus monkeys. | 2019 | Details |
| A12069 | 30616587 | BMC Complement Altern Med | The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules. | 2019 | Details |
| A12118 | 32821461 | Medeni Med J | Evaluation of Liver Biopsy Findings and Comparison with Noninvasive Fibrosis Scores in Patients with Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A12129 | 30590868 | J Gastroenterol Hepatol | Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. | 2019 | Details |
| A12138 | 30588150 | Pediatric Health Med Ther | Interventions to improve liver enzyme screening testing in obese patients aged <18 years in a public hospital, Chicago, IL, 2017-2018. | 2018 | Details |
| A12168 | 30576537 | Hum Reprod | Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age. | 2019 | Details |
| A12181 | 30573200 | Arch Med Res | Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models. | 2018 | Details |
| A12189 | 30568947 | World J Clin Cases | Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions. | 2018 | Details |
| A12190 | 30568471 | Diabetes Metab Syndr Obes | Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis. | 2018 | Details |
| A12197 | 30566676 | J Clin Endocrinol Metab | Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content. | 2019 | Details |
| A12204 | 30563142 | Molecules | Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. | 2018 | Details |
| A12211 | 30560362 | Eur Radiol | Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model. | 2018 | Details |